enVVeno Medical (NVNO) Other financing activities (2018 - 2024)

enVVeno Medical's Other financing activities history runs 5 years deep, the most recent figure standing at -$13.5 million for Q4 2024.

• On a quarterly basis, Other financing activities changed N/A year-over-year to -$13.5 million in Q4 2024; TTM through Dec 2024 was $46000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $241000.0, up 423.91% from the prior year.
• Other financing activities slipped to -$13.5 million in Q4 2024 per NVNO's latest filing, from $13.5 million in the prior quarter.
• Across five years, Other financing activities topped out at $37.9 million in Q3 2021 and bottomed at -$37.9 million in Q4 2021.
• The 3-year median for Other financing activities is $570341.0 (2020), against an average of $1.2 million.
• Biggest YoY gain for Other financing activities was 5898.49% in 2021; the steepest drop was 511.04% in 2021.
• Year by year, Other financing activities stood at $9.2 million in 2020, then sank by 511.04% to -$37.9 million in 2021, then soared by 64.25% to -$13.5 million in 2024.
• Per Business Quant, the three latest NVNO Other financing activities figures stand at -$13.5 million (Q4 2024), $13.5 million (Q3 2024), and $46000.0 (Q1 2024).